 euronews |
AstraZeneca loses US drug patent judgment
Financial Times AstraZeneca’s portfolio of patent-protected drugs has been trimmed back after the pharma group lost a legal judgment in the US that will open up an asthma medication to generic competition. The Anglo-Swedish company said on Tuesday that it disagreed … AstraZeneca suffers fresh drug patent setback in USFox Business |
Join the conversation and have a little fun at Capitalstool.com. If you are a new visitor to the Stool, please register and join in! To post your observations and charts, and snide, but good-natured, comments, click here to register. Be sure to respond to the confirmation email which is sent instantly. If not in your inbox, check your spam filter.
